Abstract:BackgroundExosomes are small membrane-bound vesicles that contribute to tumor progression and metastasis by mediating cell-to-cell communication and modifying the tumor microenvironment at both local and distant sites. However, little is known about the predominant factors in exosomes that contribute to breast cancer (BC) progression. MTA1 is a transcriptional co-regulator that can act as both a co-activator and co-repressor to regulate pathways that contribute to cancer development. MTA1 is also one of the most up-regulated proteins in cancer, whose expression correlates with cancer progression, poor prognosis and increased metastatic potential.MethodsWe identified MTA1 in BC exosomes by antibody array and confirmed expression of exosome-MTA1 across five breast cancer cells lines. Ectopic expression of tdTomato-tagged MTA1 and exosome transfer were examined by fluorescent microscopy. CRISPR/Cas9 genetic engineering was implemented to knockout MTA1 in MCF7 and MDA-MB-231 breast cancer cells. Reporter assays were used to monitor hypoxia and estrogen receptor signaling regulation by exosome-MTA1 transfer.ResultsEctopic overexpression of tdTomato-MTA1 in BC cell lines demonstrated exosome transfer of MTA1 to BC and vascular endothelial cells. MTA1 knockout in BC cells reduced cell proliferation and attenuated the hypoxic response in these cells, presumably through its co-repressor function, which could be rescued by the addition of exosomes containing MTA1. On the other hand, consistent with its co-activator function, estrogen receptor signaling was enhanced in MTA1 knockout cells and could be reversed by addition of MTA1-exosomes. Importantly, MTA1 knockout sensitized hormone receptor negative cells to 4-hydroxy tamoxifen treatment, which could be reversed by the addition of MTA1-exosomes.ConclusionsThis is the first report showing that BC exosomes contain MTA1 and can transfer it to other cells resulting in changes to hypoxia and estrogen receptor signaling in the tumor microenvironment. These results, collectively, provide evidence suggesting that exosome-mediated transfer of MTA1 contributes to BC progression by modifying cellular responses to important signaling pathways and that exosome-MTA1 may be developed as a biomarker and therapeutic target for BC.

Metastasis-associated protein 1: A potential driver and regulator of the hallmarks of cancer

Role of MTA1 in Cancer Progression and Metastasis

Metastasis-Associated Protein 1/nucleosome Remodeling and Histone Deacetylase Complex in Cancer

Physiological functions of MTA family of proteins

Malat1-Mediated Tumorigenesis

Unravelling The Complexity And Functions Of Mta Coregulators In Human Cancer

Molecular Functions and Significance of the Mta Family in Hormone-Independent Cancer

Bidirectional Autoregulatory Mechanism of Metastasis-Associated Protein 1-Alternative Reading Frame Pathway in Oncogenesis

MTA1, a Novel ATP Synthase Complex Modulator, Enhances Colon Cancer Liver Metastasis by Driving Mitochondrial Metabolism Reprogramming

The Many Faces of MTA3 Protein in Normal Development and Cancers.

Metastasis-associated Protein 1 Drives Tumor Cell Migration and Invasion Through Transcriptional Repression of RING Finger Protein 144A.

MTA1 Promotes Metastasis of MPM Via Suppression of E-cadherin

Bioinformatic Exploration of Mta1-Regulated Gene Networks in Colon Cancer

Mechanism of MTA1 Protein Overexpression-Linked Invasion. MTA1 Regulation of Hyaluronan-Mediated Motility Receptor (HMMR) Expression and Function.

MTA1 is Up-regulated in Colorectal Cancer and is Inversely Correlated with Lymphatic Metastasis.

Gene Profiling of MTA1 Identifies Novel Gene Targets and Functions.

MTA 1 , an independent prognostic factor , promotes melanoma cell invasion by induction of EMT

Role of Metastasis-Associated Protein 1 in Prognosis of Patients with Digestive Tract Cancers: A Meta-Analysis

Metastasis-associated protein 1 (MTA1) is transferred by exosomes and contributes to the regulation of hypoxia and estrogen signaling in breast cancer cells

Crosstalk between VEGF and MTA1 signaling pathways contribute to aggressiveness of breast carcinoma

Clinicopathological and Prognostic Significance of Metastasis-Associated Protein 1 Expression and Its Correlation with Angiogenesis in Lung Invasive Adenocarcinomas, Based on the 2011 IASLC/ATS/ERS Classification